Historical record - last NADAC effective date: 10/18/2017
Product Information
AMOX-CLAV 250-125 MG TABLET is a generic product labeled by Cambridge Therapeutics Technologies, LLC, priced at $2.4097 per EA under NDC 70882011120. Its NADAC has been published 30 times since Jan 18, 2017.
FDA first approved this application on Aug 23, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Amoxicillin and Clavulanate Potassium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250; 125 mg/1; mg/1
Manufacturer
Cambridge Therapeutics Technologies, LLCNDC
70882011120
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
10/18/2017
Active Ingredients
AMOXICILLIN; CLAVULANATE POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA065189FDA Approved
8/23/2005
TE Code
AB
On Market Since
8/23/2005
Pharmacological Classes
Price Statistics
The NADAC for AMOX-CLAV 250-125 MG TABLET has been published 30 times since Jan 18, 2017, and over the history we have for it it has declined 40.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.4097 per EA |
|---|---|
| All-time high | $4.0657 (Apr 12, 2017) |
| All-time low | $2.4097 (Oct 18, 2017) |
| Median price | $3.6650 |
| Average price | $3.4925 |
| Largest weekly change | -20.9% (Aug 30, 2017) |
| Weeks tracked | 30 |
| Tracking since | Jan 18, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-40.7%
Last surveyed Nov 8, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMOX-CLAV 250-125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AMOX-CLAV 250-125 MG TABLET, manufactured by Cambridge Therapeutics Technologies, LLC, is $2.4097 per EA (NDC 70882011120), effective Nov 8, 2017.
How has the price of AMOX-CLAV 250-125 MG TABLET changed over time?
Over the history we have for it, the NADAC for AMOX-CLAV 250-125 MG TABLET has declined 40.7%. It has been tracked across 30 weekly CMS publications since Jan 18, 2017.
What are the highest and lowest recorded NADAC prices for AMOX-CLAV 250-125 MG TABLET?
Since Jan 18, 2017, the NADAC for AMOX-CLAV 250-125 MG TABLET has ranged from a low of $2.4097 (Oct 18, 2017) to a high of $4.0657 (Apr 12, 2017), with a median of $3.6650 per EA.
Are there cheaper alternatives to AMOX-CLAV 250-125 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMOX-CLAV 250-125 MG TABLET, is $1.5983 per EA — about 34% below AMOX-CLAV 250-125 MG TABLET.
Who manufactures AMOX-CLAV 250-125 MG TABLET?
AMOX-CLAV 250-125 MG TABLET (NDC 70882011120) is labeled by Cambridge Therapeutics Technologies, LLC, and CMS classifies it as a generic product.